NOVA EYE MEDICAL LIMITED - Announcements

0.00%

14.0¢

Market Cap $39.85M

Technology Scientific & Technical Instruments

Nova Eye Medical Limited is an Australia-based medical technology company that develops,... Nova Eye Medical Limited is an Australia-based medical technology company that develops, manufactures, and sells a portfolio of proprietary ophthalmic treatment technologies and devices. The Company operates through three segments: AlphaRET, and Glaucoma surgical devices. The Company’s AlphaRET segment is responsible for the commercialization of the 2RT ophthalmic laser, which is an ophthalmic laser developed for the therapy of patients in the early to intermediate stages of age-related macular degeneration (AMD). 2RT is a patented nano-pulse laser device that rejuvenates retinal structures compromised by AMD. The Glaucoma Surgical Devices segment includes the designing, manufacturing, marketing, and sale of the iTrack, iTrack Advance and the Molteno3 glaucoma surgical device. The Molteno3 glaucoma drainage device platform is designed to enhance surgical utility and optimize clinical outcomes for long-term intraocular pressure (IOP) control in cases of severe glaucoma.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

EYE	Change in substantial holding from AEF		29/07/21	189.88KB	Share
EYE	FY21 Trading Update	PRICE SENSITIVE	20/07/21	337.54KB	Share
EYE	Shareholder letter holders of less than marketable Parcel		15/07/21	435.77KB	Share
EYE	Share Sale Facility for Less Than Marketable Parcels		15/07/21	164.18KB	Share
EYE	IDE Application for 2RT filed with the FDA		05/07/21	302.19KB	Share
EYE	2RT to be Featured at the 2021 Meeting of ARVO		03/05/21	208.93KB	Share
EYE	Change in substantial holding from AEF		30/04/21	208.63KB	Share
EYE	First Patient enrolled in MAGIC Clinical Trial	PRICE SENSITIVE	30/04/21	283.1KB	Share
EYE	2RT Post LEAD Review Shows Improved Treatment Benefits	PRICE SENSITIVE	05/03/21	553.77KB	Share
EYE	Clinical trial to Assess Efficacy and Safety of i Track	PRICE SENSITIVE	02/03/21	299.36KB	Share
EYE	Investor presentation Half year Results 31 December 2020	PRICE SENSITIVE	25/02/21	1.25MB	Share
EYE	Half Year Results Discussion	PRICE SENSITIVE	25/02/21	319.37KB	Share
EYE	Half Year Accounts	PRICE SENSITIVE	25/02/21	426.23KB	Share
EYE	Notice of Upcoming Investor Call		18/02/21	284.25KB	Share
EYE	Change in substantial holding from AEF		14/12/20	218.49KB	Share
EYE	Appendix 2A Conversion of Performance Rights		09/12/20	275.45KB	Share
EYE	Appendix 3G Issue of Options and Performance Rights		09/12/20	276.39KB	Share
EYE	AGM Poll Results		27/11/20	47.92KB	Share
EYE	AGM Chairman's Address		27/11/20	164.31KB	Share
EYE	AGM presentation and update		27/11/20	878.87KB	Share
EYE	Sales Update	PRICE SENSITIVE	25/11/20	293.03KB	Share
EYE	2RT Clinical Update		16/11/20	293.85KB	Share
EYE	Establishment of AlpaRET	PRICE SENSITIVE	26/10/20	779.27KB	Share
EYE	Notice of Annual General Meeting/Proxy Form		26/10/20	387.5KB	Share
EYE	AGM date and Director Nomnations		08/10/20	151.93KB	Share
EYE	Date of AGM and Director Nominations		08/10/20	339.5KB	Share
EYE	Appendix 03Y Mr T Spurling		25/09/20	222.66KB	Share
EYE	Change in Substantial Holding from AEF		18/09/20	195.37KB	Share
EYE	Change in Substantial Holding from AEF		10/09/20	197.88KB	Share
EYE	Appendix 3Z Mr Mangano		31/08/20	834.93KB	Share
EYE	Director Resignation		31/08/20	225.66KB	Share
EYE	Appendix 3X Mr Spurling		31/08/20	970.32KB	Share
EYE	Director Appointment		31/08/20	226.7KB	Share
EYE	FY20 Results presentation	PRICE SENSITIVE	31/08/20	874.81KB	Share
EYE	Appendix 4G and Corporate Governance Statement		28/08/20	763.4KB	Share
EYE	FY 20 Results	PRICE SENSITIVE	28/08/20	152.25KB	Share
EYE	Notice of upcoming investor call		28/08/20	150.75KB	Share
EYE	Full Year Statutory Accounts	PRICE SENSITIVE	28/08/20	1.66MB	Share
EYE	Change in substantial Holding from AEF		20/08/20	190.02KB	Share
EYE	Australian Tax Office Class Ruling on Capital Gain	PRICE SENSITIVE	14/08/20	349.35KB	Share
EYE	Multicentre Study Results Molteno3 Glaucoma Drainage Device		05/08/20	155.13KB	Share
EYE	Change Of Registered Office		05/08/20	225KB	Share
EYE	Acquisition of Molteno Ophthalmology Assets	PRICE SENSITIVE	03/08/20	85.15KB	Share
EYE	Payment to Shareholders of Capital Return and Dividend		29/07/20	83.87KB	Share
EYE	Updated Timetable for Capital Return & Dividend Payment	PRICE SENSITIVE	16/07/20	158.9KB	Share
EYE	Dividend/Distribution - EYE	PRICE SENSITIVE	16/07/20	22.46KB	Share
EYE	Return of Capital - EYE	PRICE SENSITIVE	16/07/20	22.55KB	Share
EYE	Pause in Trading	PRICE SENSITIVE	16/07/20	115.29KB	Share
EYE	Cancellation of Employee Options		15/07/20	219.71KB	Share
EYE	Molteno Acquistion	PRICE SENSITIVE	02/07/20	172.03KB	Share
EYE	Change of Company Name	PRICE SENSITIVE	01/07/20	182.1KB	Share
EYE	Completion of Lumibird Transaction	PRICE SENSITIVE	30/06/20	112.36KB	Share
EYE	Change in Substantial Holding from AEF		30/06/20	88.32KB	Share
EYE	Sale of Ellex Lasers & Ultrasound Now Unconditional	PRICE SENSITIVE	26/06/20	109.9KB	Share
EYE	Resignation & Appointment of Company Secretary		24/06/20	110.77KB	Share
EYE	Ceasing to be a substantial holder		15/06/20	135KB	Share
EYE	Change in substantial holding from AEF		15/06/20	209.43KB	Share
EYE	ACCC clears Ellex Lumibird transaction	PRICE SENSITIVE	11/06/20	105.24KB	Share
EYE	AXX: Lumibird-Ellex deal not opposed	PRICE SENSITIVE	11/06/20	140.26KB	Share
EYE	Update on sale of L&U Business to Lumibird		01/05/20	105.77KB	Share
EYE	Results of Meeting		24/04/20	206.18KB	Share
EYE	Chairman's Address to Shareholders	PRICE SENSITIVE	24/04/20	685.35KB	Share
EYE	Update to EGM location and structure		14/04/20	690.33KB	Share
EYE	Change in substantial holding		14/04/20	94.13KB	Share
EYE	Ellex Shareholders to vote on Lumibird transaction	PRICE SENSITIVE	24/03/20	141.61KB	Share
EYE	Notice of Extraordinary General Meeting/Proxy Form		24/03/20	1.89MB	Share
EYE	Forfeit of options		28/02/20	112.09KB	Share
EYE	Investor Presentation FY2020 H1	PRICE SENSITIVE	20/02/20	1.21MB	Share
EYE	Half Yearly Report and Accounts	PRICE SENSITIVE	20/02/20	878.2KB	Share
EYE	Resignation of Interim CEO	PRICE SENSITIVE	18/02/20	113KB	Share
EYE	Change in substantial holding		21/01/20	172.58KB	Share
EYE	Change in substantial holding		14/01/20	166.7KB	Share
EYE	Change in substantial holding		31/12/19	99.12KB	Share
EYE	Reinstatement to Official Quotation	PRICE SENSITIVE	24/12/19	68.73KB	Share
EYE	$100M Lasers & Ultrasound business sale to Lumibird Group	PRICE SENSITIVE	24/12/19	188.6KB	Share
EYE	Extension to suspension from official quotation		12/12/19	110.9KB	Share
EYE	Final Director's Interest Notice		29/11/19	186.23KB	Share
EYE	Results of Meeting		28/11/19	255.77KB	Share
EYE	2019 AGM Presentation	PRICE SENSITIVE	28/11/19	975.67KB	Share
EYE	CEO address	PRICE SENSITIVE	28/11/19	141.31KB	Share
EYE	Chairman's Address to Shareholders		28/11/19	251.7KB	Share
EYE	Suspension from Official Quotation	PRICE SENSITIVE	28/11/19	176.06KB	Share
EYE	Director Retirement		06/11/19	77.37KB	Share
EYE	Notice of Annual General Meeting/Proxy Form		25/10/19	4.85MB	Share
EYE	Annual Report to shareholders/ Letter to Shareholders		25/10/19	1.01MB	Share
EYE	Change of Director's Interest Notice		23/10/19	153.45KB	Share
EYE	Initial Director's Interest Notice		23/10/19	106.38KB	Share
EYE	Appendix 3B		01/10/19	654.02KB	Share
EYE	Corporate Governance Statement & 4G		29/08/19	418.98KB	Share
EYE	ELX FY19 ASX Release & Investor Presentation	PRICE SENSITIVE	29/08/19	995.98KB	Share
EYE	Full Year Statutory Accounts	PRICE SENSITIVE	29/08/19	956.65KB	Share
EYE	CEO employment contract		20/08/19	110.63KB	Share
EYE	Becoming a substantial holder		19/08/19	148.3KB	Share
EYE	Ellex FY19 Investor Conference Call Details		19/08/19	110.17KB	Share
EYE	Company Secretary Appointment/Resignation		19/07/19	80.16KB	Share
EYE	Appointment of Interim CEO and trading update	PRICE SENSITIVE	19/07/19	115.74KB	Share
EYE	Lead Shows Positive 2RT Benefits in iAMD Patients at 4 Years	PRICE SENSITIVE	08/07/19	122.49KB	Share
EYE	Investor Presentation May 2019	PRICE SENSITIVE	27/05/19	1.05MB	Share
EYE	Change in substantial holding from AEF		09/05/19	310.96KB	Share
EYE	Innovative New Ultrasound Launch at ASCRS		06/05/19	151.95KB	Share

EYE Change in substantial holding from AEF
29/07/21		189.88KB	Share
EYE FY21 Trading Update
20/07/21	PRICE SENSITIVE	337.54KB	Share
EYE Shareholder letter holders of less than marketable Parcel
15/07/21		435.77KB	Share
EYE Share Sale Facility for Less Than Marketable Parcels
15/07/21		164.18KB	Share
EYE IDE Application for 2RT filed with the FDA
05/07/21		302.19KB	Share
EYE 2RT to be Featured at the 2021 Meeting of ARVO
03/05/21		208.93KB	Share
EYE Change in substantial holding from AEF
30/04/21		208.63KB	Share
EYE First Patient enrolled in MAGIC Clinical Trial
30/04/21	PRICE SENSITIVE	283.1KB	Share
EYE 2RT Post LEAD Review Shows Improved Treatment Benefits
05/03/21	PRICE SENSITIVE	553.77KB	Share
EYE Clinical trial to Assess Efficacy and Safety of i Track
02/03/21	PRICE SENSITIVE	299.36KB	Share
EYE Investor presentation Half year Results 31 December 2020
25/02/21	PRICE SENSITIVE	1.25MB	Share
EYE Half Year Results Discussion
25/02/21	PRICE SENSITIVE	319.37KB	Share
EYE Half Year Accounts
25/02/21	PRICE SENSITIVE	426.23KB	Share
EYE Notice of Upcoming Investor Call
18/02/21		284.25KB	Share
EYE Change in substantial holding from AEF
14/12/20		218.49KB	Share
EYE Appendix 2A Conversion of Performance Rights
09/12/20		275.45KB	Share
EYE Appendix 3G Issue of Options and Performance Rights
09/12/20		276.39KB	Share
EYE AGM Poll Results
27/11/20		47.92KB	Share
EYE AGM Chairman's Address
27/11/20		164.31KB	Share
EYE AGM presentation and update
27/11/20		878.87KB	Share
EYE Sales Update
25/11/20	PRICE SENSITIVE	293.03KB	Share
EYE 2RT Clinical Update
16/11/20		293.85KB	Share
EYE Establishment of AlpaRET
26/10/20	PRICE SENSITIVE	779.27KB	Share
EYE Notice of Annual General Meeting/Proxy Form
26/10/20		387.5KB	Share
EYE AGM date and Director Nomnations
08/10/20		151.93KB	Share
EYE Date of AGM and Director Nominations
08/10/20		339.5KB	Share
EYE Appendix 03Y Mr T Spurling
25/09/20		222.66KB	Share
EYE Change in Substantial Holding from AEF
18/09/20		195.37KB	Share
EYE Change in Substantial Holding from AEF
10/09/20		197.88KB	Share
EYE Appendix 3Z Mr Mangano
31/08/20		834.93KB	Share
EYE Director Resignation
31/08/20		225.66KB	Share
EYE Appendix 3X Mr Spurling
31/08/20		970.32KB	Share
EYE Director Appointment
31/08/20		226.7KB	Share
EYE FY20 Results presentation
31/08/20	PRICE SENSITIVE	874.81KB	Share
EYE Appendix 4G and Corporate Governance Statement
28/08/20		763.4KB	Share
EYE FY 20 Results
28/08/20	PRICE SENSITIVE	152.25KB	Share
EYE Notice of upcoming investor call
28/08/20		150.75KB	Share
EYE Full Year Statutory Accounts
28/08/20	PRICE SENSITIVE	1.66MB	Share
EYE Change in substantial Holding from AEF
20/08/20		190.02KB	Share
EYE Australian Tax Office Class Ruling on Capital Gain
14/08/20	PRICE SENSITIVE	349.35KB	Share
EYE Multicentre Study Results Molteno3 Glaucoma Drainage Device
05/08/20		155.13KB	Share
EYE Change Of Registered Office
05/08/20		225KB	Share
EYE Acquisition of Molteno Ophthalmology Assets
03/08/20	PRICE SENSITIVE	85.15KB	Share
EYE Payment to Shareholders of Capital Return and Dividend
29/07/20		83.87KB	Share
EYE Updated Timetable for Capital Return & Dividend Payment
16/07/20	PRICE SENSITIVE	158.9KB	Share
EYE Dividend/Distribution - EYE
16/07/20	PRICE SENSITIVE	22.46KB	Share
EYE Return of Capital - EYE
16/07/20	PRICE SENSITIVE	22.55KB	Share
EYE Pause in Trading
16/07/20	PRICE SENSITIVE	115.29KB	Share
EYE Cancellation of Employee Options
15/07/20		219.71KB	Share
EYE Molteno Acquistion
02/07/20	PRICE SENSITIVE	172.03KB	Share
EYE Change of Company Name
01/07/20	PRICE SENSITIVE	182.1KB	Share
EYE Completion of Lumibird Transaction
30/06/20	PRICE SENSITIVE	112.36KB	Share
EYE Change in Substantial Holding from AEF
30/06/20		88.32KB	Share
EYE Sale of Ellex Lasers & Ultrasound Now Unconditional
26/06/20	PRICE SENSITIVE	109.9KB	Share
EYE Resignation & Appointment of Company Secretary
24/06/20		110.77KB	Share
EYE Ceasing to be a substantial holder
15/06/20		135KB	Share
EYE Change in substantial holding from AEF
15/06/20		209.43KB	Share
EYE ACCC clears Ellex Lumibird transaction
11/06/20	PRICE SENSITIVE	105.24KB	Share
EYE AXX: Lumibird-Ellex deal not opposed
11/06/20	PRICE SENSITIVE	140.26KB	Share
EYE Update on sale of L&U Business to Lumibird
01/05/20		105.77KB	Share
EYE Results of Meeting
24/04/20		206.18KB	Share
EYE Chairman's Address to Shareholders
24/04/20	PRICE SENSITIVE	685.35KB	Share
EYE Update to EGM location and structure
14/04/20		690.33KB	Share
EYE Change in substantial holding
14/04/20		94.13KB	Share
EYE Ellex Shareholders to vote on Lumibird transaction
24/03/20	PRICE SENSITIVE	141.61KB	Share
EYE Notice of Extraordinary General Meeting/Proxy Form
24/03/20		1.89MB	Share
EYE Forfeit of options
28/02/20		112.09KB	Share
EYE Investor Presentation FY2020 H1
20/02/20	PRICE SENSITIVE	1.21MB	Share
EYE Half Yearly Report and Accounts
20/02/20	PRICE SENSITIVE	878.2KB	Share
EYE Resignation of Interim CEO
18/02/20	PRICE SENSITIVE	113KB	Share
EYE Change in substantial holding
21/01/20		172.58KB	Share
EYE Change in substantial holding
14/01/20		166.7KB	Share
EYE Change in substantial holding
31/12/19		99.12KB	Share
EYE Reinstatement to Official Quotation
24/12/19	PRICE SENSITIVE	68.73KB	Share
EYE $100M Lasers & Ultrasound business sale to Lumibird Group
24/12/19	PRICE SENSITIVE	188.6KB	Share
EYE Extension to suspension from official quotation
12/12/19		110.9KB	Share
EYE Final Director's Interest Notice
29/11/19		186.23KB	Share
EYE Results of Meeting
28/11/19		255.77KB	Share
EYE 2019 AGM Presentation
28/11/19	PRICE SENSITIVE	975.67KB	Share
EYE CEO address
28/11/19	PRICE SENSITIVE	141.31KB	Share
EYE Chairman's Address to Shareholders
28/11/19		251.7KB	Share
EYE Suspension from Official Quotation
28/11/19	PRICE SENSITIVE	176.06KB	Share
EYE Director Retirement
06/11/19		77.37KB	Share
EYE Notice of Annual General Meeting/Proxy Form
25/10/19		4.85MB	Share
EYE Annual Report to shareholders/ Letter to Shareholders
25/10/19		1.01MB	Share
EYE Change of Director's Interest Notice
23/10/19		153.45KB	Share
EYE Initial Director's Interest Notice
23/10/19		106.38KB	Share
EYE Appendix 3B
01/10/19		654.02KB	Share
EYE Corporate Governance Statement & 4G
29/08/19		418.98KB	Share
EYE ELX FY19 ASX Release & Investor Presentation
29/08/19	PRICE SENSITIVE	995.98KB	Share
EYE Full Year Statutory Accounts
29/08/19	PRICE SENSITIVE	956.65KB	Share
EYE CEO employment contract
20/08/19		110.63KB	Share
EYE Becoming a substantial holder
19/08/19		148.3KB	Share
EYE Ellex FY19 Investor Conference Call Details
19/08/19		110.17KB	Share
EYE Company Secretary Appointment/Resignation
19/07/19		80.16KB	Share
EYE Appointment of Interim CEO and trading update
19/07/19	PRICE SENSITIVE	115.74KB	Share
EYE Lead Shows Positive 2RT Benefits in iAMD Patients at 4 Years
08/07/19	PRICE SENSITIVE	122.49KB	Share
EYE Investor Presentation May 2019
27/05/19	PRICE SENSITIVE	1.05MB	Share
EYE Change in substantial holding from AEF
09/05/19		310.96KB	Share
EYE Innovative New Ultrasound Launch at ASCRS
06/05/19		151.95KB	Share

REFRESH

First 2 3 4 5 6

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 14.0¢		Change 0.000(0.00%)		Mkt cap ! $39.85M

Open	High	Low	Value	Volume
14.0¢	14.0¢	14.0¢	$153	1.094K

Buyers (Bids)

No.	Vol.	Price($)
7	282523	14.0¢

Sellers (Offers)

Price($)	Vol.	No.
14.5¢	341748	4

View Market Depth

No.	Vol.	Price($)
7	282523	0.140
12	799187	0.135
8	336420	0.130
6	262110	0.125
3	96666	0.120

Price($)	Vol.	No.
0.145	341748	4
0.150	356190	6
0.155	155560	2
0.160	155290	3
0.165	116209	4

Last trade - 10.52am 13/08/2025 (20 minute delay)


Last 14.0¢		Change 0.000 ( 0.00 %)
Open	High	Low	Volume
14.0¢	14.0¢	14.0¢	7500
Last updated 10.52am 13/08/2025 ?

EYE (ASX) Chart

NOVA EYE MEDICAL LIMITED - Announcements

Corporate SpotlightNot Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories

Corporate Spotlight
Not Yet Available